EPI HEALTH, LLC – Trademark Portfolio
Entity Type: 16
EPI HEALTH, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CLODERM, RHOFADE, SITAVIG, MINOLIRA, and EPI HEALTH ADVANCING DERMATOLOGY. The owner is based in CHARLESTON, SC.
134 COLUMBUS STREET
CHARLESTON, SC 29403
Showing of trademarks Trademarks
Trademark Classifications
EPI HEALTH, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does EPI HEALTH, LLC have?
EPI HEALTH, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 9 cancelled.
What trademark classes does EPI HEALTH, LLC file in?
EPI HEALTH, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are EPI HEALTH, LLC's most well-known trademarks?
EPI HEALTH, LLC's registered trademark portfolio includes well-known marks such as CLODERM, RHOFADE, SITAVIG, MINOLIRA, and EPI HEALTH ADVANCING DERMATOLOGY. These are among 5 currently registered trademarks in the portfolio.
What is EPI HEALTH, LLC's trademark registration success rate?
EPI HEALTH, LLC has a 33% trademark registration rate, with 5 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.